Table 2. Efficacy estimates.
| |
Number (% 95% CI) |
|---|---|
| (n=31) | |
| Best response |
|
| Complete response | 0 (0) |
| Partial response | 14 (45; 27.3–64.0) |
| Stable disease | 14 (45; 27.3–64.0) |
| Progressive disease | 3 (9.7; 2.0–25.8) |
| Overall response rate | 14 (45; 27.3–64.0) |
| Disease control rate |
28 (90; 79.4–100) |
| Median PFS |
10.6 Months (4.8–24.2) |
| Median OS | 20.3 Months (9.1–25.1) |
Abbreviations: CI=confidence interval; OS=overall survival; PFS=progression-free survival.